Stay updated on PD-L1 CAR-NK & Pembrolizumab Combo in Gastric/Head Neck Clinical Trial
Sign up to get notified when there's something new on the PD-L1 CAR-NK & Pembrolizumab Combo in Gastric/Head Neck Clinical Trial page.

Latest updates to the PD-L1 CAR-NK & Pembrolizumab Combo in Gastric/Head Neck Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a new version of the content has been published. This update appears in the site's revision history and reflects ongoing page maintenance.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s displayed software revision/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check30 days agoChange DetectedThe history now shows an added Revision: v3.5.2 and removes the previous Revision: v3.5.0.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded a new history entry for 2026-04-08 (Study Status) with 2026-04-07; removed the 2025-12-24 entry.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history now includes a new revision: v3.5.0 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page history adds Revision: v3.4.2 and removes the funding-lapse notice and Revision: v3.4.1 from the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PD-L1 CAR-NK & Pembrolizumab Combo in Gastric/Head Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1 CAR-NK & Pembrolizumab Combo in Gastric/Head Neck Clinical Trial page.